These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5306982)

  • 1. [Experience with a new hypotensive agent].
    Kühns K; Janocha U; Magnus D
    Hospital (Rio J); 1967 Oct; 72(4):1167-74. PubMed ID: 5306982
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha-methyl dopa (aldomet) as a hypotensive agent in the treatment of toxaemias of pregnancy.
    Chan WH; Chan DP
    Singapore Med J; 1968 Dec; 9(4):271-5. PubMed ID: 5728866
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences on a new derivative of aminoguanidine with hypotensive action].
    Battaglia A; Raineri A
    Clin Ter; 1966 Feb; 36(4):318-23. PubMed ID: 5941235
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of alpha-methyl-dopa (Dopegyt) and other antihypertensive drugs (guanethidine, bethanidine) on the isotope renogram.
    Radó J; Bános C; Takó J; Szabó T; Borbély L; Szende L; Kapus I; Nagy M
    Ther Hung; 1969; 17(2):76-82. PubMed ID: 5807612
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical picture and therapy of hypertension].
    Bernsmeier A
    Munch Med Wochenschr; 1967 Sep; 109(36):1837-45. PubMed ID: 5631765
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of essential and nephrogenic hypertension using alpha-methyldopa and alpha-methyldopa+hydrochlorothiazide. Comparative study].
    Sales EJ; Villa JJ; Mendez MA
    Prensa Med Argent; 1971 Jun; 58(14):741-8. PubMed ID: 5091433
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic trials with the new antihypertensive agent Tadip].
    Stein G
    Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The broad-spectrum antihypertensive agent Tadip in slight and moderate hypertension].
    Kempf E
    Med Monatsschr; 1968 Jun; 22(6):270-5. PubMed ID: 5720912
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative human studies of a new anti-hypertensive drug (2,6-dichloro-benzylidene-aminoguanidine acetate) and methyldopa in hypertensive patients].
    Baldrighi V; Baldrighi G; Ronzoni L; Aiazzi L; Caprioli G
    Arch Sci Med (Torino); 1977; 134(2):185-92. PubMed ID: 869702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of arterial hypertension with alpha-methyldopa].
    Herteanu H; Bucur V
    Med Interna (Bucur); 1969 Sep; 21(9):1119-26. PubMed ID: 5378243
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of guanoclor and methyldopa in the treatment of severe hypertension.
    Mackinnon J; el-Baz LM
    Br J Clin Pract; 1971 Mar; 25(3):135-7. PubMed ID: 4929159
    [No Abstract]   [Full Text] [Related]  

  • 14. The long-term effectiveness of methyldopa in hypertension.
    Okun R; Roth SE; Gordon A; Maxwell MH
    Calif Med; 1966 Jan; 104(1):46-50. PubMed ID: 5909253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha-methyldopa in the treatment of arterial hypertension. Clinical study of 150 patients].
    Ferrario G
    Minerva Med; 1973 Apr; 64(21):1098-103. PubMed ID: 4703861
    [No Abstract]   [Full Text] [Related]  

  • 16. The combined effect of propranolol with bethanidine or methyldopa in hypertension.
    Prichard BN
    Adv Clin Pharmacol; 1976; 11():107-13. PubMed ID: 1032568
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of hypertension with Leron (cyclacenin) and Tadip (cyclacenin and alpha-methyldopa)].
    Stampfer E
    Wien Med Wochenschr; 1968 Jun; 118(24):551-4. PubMed ID: 5711781
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC; De A; Cameron EG
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences from medical practice with a combination of l-alpha-methyldopa and cyclazenin (Tadip)].
    Terhedebrügge A
    Med Welt; 1967 Dec; 48():2928-30. PubMed ID: 5610312
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dopegyt (alpha-methyldopa) in arterial hypertension].
    Kedra M; Koziara Z
    Pol Tyg Lek; 1971 Jun; 26(25):963-5. PubMed ID: 5564519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.